How to cite item

The role of patient advocacy organizations in shaping medical research: the Pompe model

  
@article{ATM25915,
	author = {Tiffany House and Kevin O’Donnell and Raymond Saich and Fabio Di Pietro and Ria Broekgaarden and Allan Muir and Thomas Schaller},
	title = {The role of patient advocacy organizations in shaping medical  research: the Pompe model},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {13},
	year = {2019},
	keywords = {},
	abstract = {The Pompe model is the term used by the Pompe community to describe the relationship that exists between the patient community, the medical/scientific community, and industry. The development of the Pompe model represented a new paradigm for the involvement of patients in new treatments—and also for scientists and pharmaceutical companies. It saw patients developing a sense of agency, of involvement in the process of treatment development rather than powerless recipients or (if lucky) occasional spectators. At the same time, as described below, it benefited the other partners in the process with the result that the different components of the model added up to more than the sum of their parts. However, in order for this to happen, each part had to undergo a transformation in mindset. The development of enzyme replacement therapy (ERT) for Pompe disease represented a unique set of circumstances and individuals that helped to bring about this change and, in doing so, created a model that has had far wider applications.},
	issn = {2305-5847},	url = {http://atm.amegroups.com/article/view/25915}
}